With AI-powered antigen design, Xpotlight epitope-specific antibody discovery enables precision targeting to develop antibodies with unique functions.
- RAISE THE BAR
AI-Powered Antibody Discovery Solutions Down Arrow
- INTEGRATED ANTIBODY DISCOVERY
Searching for Functional and Developable Hits?
Deeply mine vast immune repertoires using an integrated hit-generation platform to deliver rare binders with unique binding and functional properties.
- INTEGRATED ANTIBODY DISCOVERY
Trying to Target Specific Epitopes?
Access AI-designed antigens to target specific conformational epitopes and execute unique therapeutic functions.
In Vivo
Customized immunization protocol & AI-designed antigen
In Vitro
Cell-free expression, high-throughput binding & functional assays
In Silico
AI-guided hit generation powered by active learning
3-IN-1 INTEGRATED HIT GENERATION PLATFORM
Trilux
Trilux is a multiplexed hit-generation platform that combines single B-cell screening, repertoire next-generation screening and phage display technologies to capture the full diversity of the immune repertoire. Trilux employs proprietary AI with active learning to identify and prioritize low-frequency rare binders, capturing unique antibodies with unique binding and functional properties.
Single B-cell Screening
Repertoire NGS
Phage Display
Step 1. Mine for Rare Functional Hits
Step 2. Perform High‑throughput Humanization
Step 3. Triage Binders Based on Developability
Step 4. Explore Epitope–function Relationship
Result: Functional Hits
Trilux accelerates and de-risks antibody discovery by identifying rare, functional antibodies and optimizing humanization workflows, paving the way for next-generation therapeutics.
- EPITOPE-SPECIFIC DISCOVERY POWERED BY AI-DESIGNED ANTIGENS
Xpotlight enables epitope-specific discovery with AI-designed antigens suitable for applications such as immunization and multiple screening approaches, including phage panning and single B-cell screening. This accelerates the identification of binders targeting specific conformational epitopes to execute unique therapeutic functions.
Precision epitope targeting
AI-designed antigens and baits to target antibodies with epitope binding specificities.
Flexible applications
AI-antigens are compatible with a range of immunization, screening, and validation approaches.
Unlock challenging functions
Discover binders with unique functions including antagonistic, agonist, and conformational epitope-specific antibodies.
CLIENT TESTIMONIAL
Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Dr. Chandan Seth Nanda
Our Services
Integrated Hit Generation
Next-Gen Engineering
Together, let’s push the boundaries of medicine.
The future of biotechnology is collaborative. We believe the best solutions come from working together with companies and researchers who share our vision. Are you ready to push the boundaries of what’s possible?